Design, Synthesis, and Biological Evaluation of Quinoxaline Bearing Tetrahydropyridine Derivatives as Anticancer, Antioxidant, and Anti-Tubercular Agents

被引:3
|
作者
Pavale, Ganesh [1 ]
Acharya, Poornima [1 ]
Korgavkar, Nilesh [2 ]
Ramana, M. M. V. [1 ]
机构
[1] Univ Mumbai, Dept Chem, Mumbai 400098, India
[2] Univ Mumbai, Mithibai Coll, Dept Chem, Mumbai, India
关键词
Quinoxaline; tetrahydropyridine; anticancer; antioxidant; anti-mycobacterial; molecular docking; ANTIPROLIFERATIVE ACTIVITY; MYCOBACTERIUM-TUBERCULOSIS; CHEMISTRY; ANTIBACTERIAL; ANTIFUNGAL; DIVERSITY; POTENT;
D O I
10.2174/1573409918666220804142753
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Background: Quinoxaline and Tetrahydropyridine derivatives showed various biological properties. The combination of these two scaffolds may contribute to good biological activity and may give novel and efficacious bioactive candidates. Objective: The present study aimed to identify bioactive agents with quinoxaline bearing tetrahydropyridine derivatives possessing anticancer, antioxidant, and anti-tubercular agents. Methods: A series of novel quinoxaline bearing tetrahydropyridine derivatives have been designed and synthesized in good yields. The synthetic protocol involves three-component Povarov reactions of 6-amino quinoxaline, propenyl guaethol, and substituted aldehydes using BF3 center dot OEt2 as catalyst. The newly synthesized molecules were evaluated for their anticancer activity against four cell lines, i.e. A-549, MCF-7, PC-3, and HepG2. Results: The results from in vitro assay indicated that compound 4a proved to be as potent as the standard drug adriamycin against all cell lines with GI50 values <10 mu g/ml. Compounds 4b, 4f, and 4i exhibited good cytotoxicity against A-549 cell line. All synthesized molecules were evaluated for their antioxidant activity and the results revealed that the compounds 4a, 4b, and 4i showed promising antioxidant activities against DPPH and H2O2 scavenging. In addition, the anti-mycobacterial activity of the synthesized compounds against MTB H37Rv strain was determined using the MABA method. The results indicate that the compounds 4a, 4b, 4g, and 4i showed better anti-mycobacterial activity than the standard drugs pyrazinamide, ciprofloxacin and streptomycin with an MIC value of 1.6 mu g/ml. Furthermore, molecular docking studies and ADME properties showed good pharmacokinetic profile and drug-likeness properties. Conclusion: These studies showed that a series of novel quinoxaline bearing tetrahydropyridine derivatives exhibit anticancer, anti-mycobacterial, and antioxidant activities.
引用
收藏
页码:414 / 424
页数:11
相关论文
共 50 条
  • [1] Design, synthesis, and biological evaluation of novel arylcarboxamide derivatives as anti-tubercular agents
    Alsayed, Shahinda S. R.
    Lun, Shichun
    Luna, Giuseppe
    Beh, Chau Chun
    Payne, Alan D.
    Foster, Neil
    Bishai, William R.
    Gunosewoyo, Hendra
    RSC ADVANCES, 2020, 10 (13) : 7523 - 7540
  • [2] Synthesis and biological evaluation of dihydroquinoline carboxamide derivatives as anti-tubercular agents
    Kumar, Gautam
    Sathe, Asawari
    Krishna, Vagolu Siva
    Sriram, Dharmarajan
    Jachak, Sanjay M.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 157 : 1 - 13
  • [3] Design, synthesis and evaluation of diarylpiperazine derivatives as potent anti-tubercular agents
    Penta, Ashok
    Franzblau, Scott
    Wan, Baojie
    Murugesan, Sankaranarayanan
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 105 : 238 - 244
  • [4] Indole Derivatives as Anti-Tubercular Agents: An Overview on their Synthesis and Biological Activities
    Reddy, Gangireddy Sujeevan
    Pal, Manojit
    CURRENT MEDICINAL CHEMISTRY, 2021, 28 (22) : 4531 - 4568
  • [5] Synthesis and evaluation of new triazolobenzothiazole derivatives as potential anti-tubercular agents
    Paranjape, SD
    Bobade, AS
    Khadse, BG
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 2001, 51 (11): : 916 - 919
  • [6] The synthesis and evaluation of triazolopyrimidines as anti-tubercular agents
    Zuniga, Edison S.
    Korkegian, Aaron
    Mullen, Steven
    Hembre, Erik J.
    Ornstein, Paul L.
    Cortez, Guillermo
    Biswas, Kallolmay
    Kumar, Naresh
    Cramer, Jeffrey
    Masquelin, Thierry
    Hipskind, Philip A.
    Odingo, Joshua
    Parish, Tanya
    BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (15) : 3922 - 3946
  • [7] Novel pyrazine based anti-tubercular agents: Design, synthesis, biological evaluation and in silico studies
    Hassan, Nayera W.
    Saudi, Manal N.
    Abdel-Ghany, Yasser S.
    Ismail, Azza
    Elzahhar, Perihan A.
    Sriram, Dharmarajan
    Nassra, Rasha
    Abdel-Aziz, Marwa M.
    El-Hawash, Soad A.
    BIOORGANIC CHEMISTRY, 2020, 96
  • [8] Biological evaluation of diazene derivatives as anti-tubercular compounds
    Cappoen, Davie
    Majce, Vita
    Uythethofken, Cynthia
    Urankar, Damijana
    Mathys, Vanessa
    Kocevar, Marijan
    Verschaeve, Luc
    Polanc, Slovenko
    Huygen, Kris
    Kosmrlj, Janez
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 74 : 85 - 94
  • [9] Synthesis and biological evaluation of novel 1,2,3-triazole derivatives as anti-tubercular agents
    Ali, Abdul Aziz
    Gogoi, Dhrubajyoti
    Chaliha, Amrita K.
    Buragohain, Alak K.
    Trivedi, Priyanka
    Saikia, Prakash J.
    Gehlot, Praveen S.
    Kumar, Arvind
    Chaturvedi, Vinita
    Sarma, Diganta
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (16) : 3698 - 3703
  • [10] Synthesis and Biological Evaluation of New Quinoxaline Derivatives as Antioxidant and Anti-Inflammatory Agents
    Burguete, Asuncion
    Pontiki, Eleni
    Hadjipavlou-Litina, Dimitra
    Ancizu, Saioa
    Villar, Raquel
    Solano, Beatriz
    Moreno, Elsa
    Torres, Enrique
    Perez, Silvia
    Aldana, Ignacio
    Monge, Antonio
    CHEMICAL BIOLOGY & DRUG DESIGN, 2011, 77 (04) : 255 - 267